Case Report: The many faces of bullous pemphigoid. [PDF]
Front Immunol, 2023 Rechtien L +4 more
europepmc +1 more source
Pyoderma gangrenosum developed from aggravated pemphigus foliaceous after dog bite. [PDF]
Dermatol Reports, 2023 Kwak JH, Na CH, Shin BS, Kim MS, Choi H.
europepmc +1 more source
Lipschütz ulceration in a 12-year-old girl following second dose of Comirnaty (Pfizer) COVID-19 vaccine. [PDF]
Int J Womens Dermatol, 2022 Frederiks AJ, Foster RS, Ricciardo B.
europepmc +1 more source
The efficacy and safety of oral microecological agents as add-on therapy for atopic dermatitis: A systematic review and meta-analysis of randomized clinical trials. [PDF]
Clin Transl Allergy, 2023 Xue P +6 more
europepmc +1 more source
Clinical Guidelines for the Use of Antipruritic Drugs in the Control of the Most Frequent Pruritic Skin Diseases in Dogs. [PDF]
Vet Sci, 2022 Bruet V +6 more
europepmc +1 more source
'COVID vaccine arm' may present after both mRNA vaccines vaccination. [PDF]
J Eur Acad Dermatol Venereol, 2021 Gregoriou S +5 more
europepmc +1 more source
Soft Glucocorticoids: Eye-Targeted Chemical Delivery Systems (CDSs) and Retrometabolic Drug Design: A Review [PDF]
, 2012 Juri Moni Borah, Pritish Chowdhury
core +2 more sources
Methylprednisolone aceponate in eczema and other inflammatory skin disorders -- a clinical update.
International journal of clinical practice, 2006 Methylprednisolone aceponate (MPA) has been shown to provide rapid, reliable and highly effective treatment of eczematous disorders, with an efficacy comparable to that of most reference topical corticosteroids. It also has excellent local and systemic tolerability.
openaire +1 more source
PRS42 Pharmacoeconomic Analysis of Methylprednisolone Aceponate for Treatment of Atopic Dermatitis and Eczema [PDF]
Value in Health, 2011 Omelyanovsky, V. +5 more
openaire +1 more source